Tumor suppression and promotion by autophagy

Area of Science:

• Cell Biology
• Molecular Biology
• Oncology

Background:

• Autophagy is a fundamental cellular process involving the degradation of cellular components, primarily mitochondria, crucial for maintaining homeostasis and reducing metabolic stress.
• Dysfunctional autophagy is implicated in various diseases, including neurodegeneration, aging, and cancer.
• Proteins regulating autophagy often function as oncogenes or tumor suppressors, highlighting its intricate connection to cancer biology.

Purpose of the Study:

• To review the complex and often contradictory role of autophagy in cancer development and progression.
• To explore how autophagy acts as both a tumor suppressor mechanism and a pro-tumorigenic factor.

Main Methods:

• Literature review focusing on the molecular mechanisms linking autophagy regulators to cancer.
• Analysis of studies investigating autophagy's impact on tumorigenesis, oxidative stress, and genomic instability.
• Examination of autophagy's cytoprotective functions in established tumors under stress conditions like hypoxia and nutrient starvation.

Main Results:

• Tumor suppressor genes inhibiting mTOR (e.g., PTEN, AMPK) stimulate autophagy, suggesting a tumor-suppressive role.
• Oncogenes activating mTOR (e.g., PI3K, Ras, AKT) inhibit autophagy, further supporting its tumor-suppressive potential.
• Autophagy inhibition can lead to oxidative stress, genomic instability, and tumorigenesis.
• Conversely, autophagy promotes tumor growth and chemoresistance in established cancers under stress conditions.

Conclusions:

• Autophagy exhibits an ambiguous role in cancer, acting as both a suppressor and a promoter depending on the context.
• Understanding this dual role is critical for developing effective cancer therapies targeting autophagy.